Learn, Analyse & Invest
only with

+91

Download Orca

To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Dr. Lal Pathlabs Ltd.

Dr. Lal Pathlabs

₹ 0.00

0.00 (0.00)%

NSE

BSE

Healthcare

Small-cap - With a market cap of ₹228.55 Cr.

EX-Date	Purpose
21 05 2021	Audited Results & Final Dividend
30 07 2021	Interim Dividend & Quarterly Results
26 10 2021	Quarterly Results
10 02 2022	Quarterly Results
17 05 2022	Audited Results & Final Dividend
28 07 2022	Quarterly Results & Interim Dividend
08 11 2022	Quarterly Results
02 02 2023	Quarterly Results
11 05 2023	Final Dividend & Audited Results
27 07 2023	Quarterly Results & Interim Dividend
02 11 2023	Quarterly Results
01 02 2024	Quarterly Results & Interim Dividend
23 10 2024	Quarterly Results & Interim Dividend
30 01 2025	Quarterly Results & Interim Dividend
25 04 2025	Audited Results & Final Dividend
31 10 2025	Interim Dividend & Bonus issue & Quarterly Results
30 01 2026	Quarterly Results & Interim Dividend

News

06-JAN-2026

Dr. Lal PathLabs sets new standard in preventive healthcare with launch of Sovaaka

The company has launched its new-age Diagnostic Experience Centre -- Sovaaka, in Gurugram

09:58 AM

26-NOV-2025

Dr. Lal PathLabs launches India’s first dedicated Complement Testing Laboratory

The Complement Laboratory is equipped with state-of-the-art immunoturbidimetric and ELISA platforms and adheres to CAP and NABL accreditation standards

03:29 PM

24-SEP-2025

Dr. Lal Pathlabs gets nod to acquire property in New Delhi

The company will pay consideration amount of up to Rs 74.51 crore for the property

12:38 PM

20-AUG-2025

Dr. Lal Pathlabs pioneers AI integration in cancer diagnosis in India

Adding this technology to regular medical practice makes diagnosing cancer faster and more reliable

11:43 AM

25-JUN-2025

Dr. Lal PathLabs expands genomics capabilities with Illumina’s NovaSeq X Series

With the integration of Illumina’s latest technology, the company can now deliver faster and more accurate genomic research insights

02:42 PM

15-APR-2025

Dr. Lal PathLabs launches test for Amyloidosis disease

With this launch, the company becomes the first diagnostic chain in South Asia to offer this highly specialized test

12:21 PM

11-MAY-2023

Dr. Lal Pathlabs reports 8% fall in Q4 consolidated net profit

Total consolidated income of the company increased by 1.55% at Rs 505.20 crore for Q4FY23

04:51 PM

15-MAR-2023

Dr. Lal PathLabs selects Kyndryl to manage IT infrastructure stack

Post onboarding, Kyndryl has been instrumental in managing the multiple cloud platforms

03:08 PM

31-JAN-2023

Dr. Lal Pathlabs’ arm gets nod to acquire further 10% stake in APRL PathLabs

The Board of Directors of the company in their meeting held on January 30, 2023 approved the same

10:00 AM